The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
How COVID-19 set the stage for a Canadian healthtech boom (BETAKIT)
In the midst of a global health crisis, an industry frustrated by commercialization obstacles is finally having a moment.
Alberta’s COVID-19 contact-tracing app a ‘security risk’ on Apple devices: privacy commissioner (GLOBAL NEWS)
Commissioner Jill Clayton said Alberta Health was mindful of privacy and security in developing the app and took reasonable steps to protect privacy.
Guelph company’s mobile COVID-19 test kit hits market and heads for Northern Ontario (TORONTO STAR)
Precision’s mobile kit, which can fit in a laptop-sized bag, can process nine tests at one time and produce results in 45 minutes.
Bellus stock drops 72% after highly anticipated drug disappoints in human trials (THE GLOBE AND MAIL)
The stock of one of Canada’s most prominent biotechnology developers, Bellus Health Inc., tanked following disappointing trial results for a drug aimed at treating individuals suffering from a chronic cough.
8 million people, 14 alerts: why some COVID-19 apps are staying silent (MIT TECHNOLOGY REVIEW)
Critics have rounded on contact tracing apps in France and Australia for sending out almost no virus notifications. But experts say it’s not a total failure—as long as we learn what went wrong.
Data analytics startup Evidation raises $45M, plots foray into virtual health (MED CITY NEWS)
Evidation Health, a startup that provides technology for virtual clinical trials, raised $45 million in series D funding. The company plans to use the funds to offer virtual health programs to research participants.
German biotech sees its coronavirus vaccine ready for approval by December (WALL STREET JOURNAL)
BioNTech CEO warns it could still take a decade to fight back a virus that has now infected millions, despite global efforts and rapid progress.
A better way to scale COVID-19 testing (HARVARD BUSINESS REVIEW)
If done right, the increased volume and predictability of assurance testing could help lower testing costs, increase innovation, and provide wider, more equitable access.
After the pandemic, doctors want their new robot helpers to stay (THE VERGE)
These machines have become the vanguard of pandemic automation, with sales for UV cleaning robots booming in recent months.
How healthy are health apps? (MOBIHEALTHNEWS)
Digital health applications are starting to make their way into regular healthcare provision. But how should they be regulated?